Last reviewed · How we verify
NCT07448792: EUKINES
EUKINES Wearable Plantar-Pressure Insole System for Rehabilitation After Total Hip Arthroplasty
NA trial testing Certified reference gait-analysis system in Hip Osteoarthritis in 200 participants. Completed in 30 November 2025.
30 November 2025
Quick facts
| Lead sponsor | Cardinal Stefan Wyszynski University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 15 December 2024 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Certified reference gait-analysis system
- EUKINES plantar-pressure insole system
- Structured postoperative rehabilitation program
Conditions studied
- Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
- Total Hip Arthroplasty (THA) — all drugs for Total Hip Arthroplasty (THA) →
- Postoperative Rehabilitation — all drugs for Postoperative Rehabilitation →
Sponsor
Cardinal Stefan Wyszynski University
Who can join
18 and older, any sex, with Hip Osteoarthritis or Total Hip Arthroplasty (THA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates a wearable plantar-pressure insole system (EUKINES) designed to support gait training during postoperative rehabilitation after primary total hip arthroplasty (THA). The trial will include 200 adults who are randomly assigned to one of four rehabilitation programs: EUKINES with real-time biofeedback, EUKINES without biofeedback, a certified commercial reference system with biofeedback, or standard rehabilitation without any gait-analysis device. All participants will receive a structured 6-week rehabilitation program after THA, and the only differences between groups concern the use of gait-analysis technology and biofeedback. The main outcomes include changes in plantar-pressure-based gait parameters (mean foot pressure and load asymmetry) and standard clinical scores of hip function and symptoms. The study will also monitor safety, device-related events, walking speed, pain, and patient and therapist ratings of usability and satisfaction. The goal is to determine whether rehabilitation supported by the EUKINES insole system is at least as effective and safe as rehabilitation supported by a certified reference system and as standard care, and to explore the feasibility of using low-cost, printed-sensor technology for routine gait assessment and future telerehabilitation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07448792
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Osteoarthritis
Currently open trials in the same condition.
- NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
- NCT07327931 — PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults · NA · recruiting
- NCT07288983 — PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery · NA · recruiting
- NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
- NCT07347041 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) · NA · recruiting
Other Cardinal Stefan Wyszynski University trials
Trials by the same sponsor.
- NCT06899464 — Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Random · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07448792 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardinal Stefan Wyszynski University
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07448792.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing